Hawaii Subject | Right-to-Try Act

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
HIHB966Intro
25%
Beginning on 1/1/2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 7/1/3000. (HD1)
[Detail][Text][Discuss]
2024-02-08
To House Consumer Protection & Commerce Committee
HIHB2024Intro
25%
Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
[Detail][Text][Discuss]
2024-01-24
To House Health Committee
HISB2023Intro
25%
Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
[Detail][Text][Discuss]
2024-01-17
To Senate Health and Human Services Committee
HISB857Intro
25%
Beginning on January 1, 2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 12/31/2050. (SD1)
[Detail][Text][Discuss]
2023-12-11
To Senate Commerce and Consumer Protection Committee
Syndicate content
feedback